188 related articles for article (PubMed ID: 31730712)
21. Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.
Hjelle LV; Gundersen PO; Oldenburg J; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Bremnes RM; Haugnes HS
Anticancer Res; 2015 Mar; 35(3):1619-25. PubMed ID: 25750319
[TBL] [Abstract][Full Text] [Related]
22. Mortality after cure of testicular seminoma.
Zagars GK; Ballo MT; Lee AK; Strom SS
J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
[TBL] [Abstract][Full Text] [Related]
23. Increased pancreatic cancer risk following radiotherapy for testicular cancer.
Hauptmann M; Børge Johannesen T; Gilbert ES; Stovall M; van Leeuwen FE; Rajaraman P; Smith SA; Weathers RE; Aleman BM; Andersson M; Curtis RE; Dores GM; Fraumeni JF; Hall P; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Lynch CF; Pukkala E; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Morton LM; Fossa SD; Travis LB
Br J Cancer; 2016 Sep; 115(7):901-8. PubMed ID: 27599043
[TBL] [Abstract][Full Text] [Related]
24. Treatment-associated leukemia following testicular cancer.
Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
[TBL] [Abstract][Full Text] [Related]
25. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
26. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P
Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
[TBL] [Abstract][Full Text] [Related]
27. Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.
Boer H; Proost JH; Nuver J; Bunskoek S; Gietema JQ; Geubels BM; Altena R; Zwart N; Oosting SF; Vonk JM; Lefrandt JD; Uges DR; Meijer C; de Vries EG; Gietema JA
Ann Oncol; 2015 Nov; 26(11):2305-10. PubMed ID: 26347114
[TBL] [Abstract][Full Text] [Related]
28. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.
Hooning MJ; Aleman BM; van Rosmalen AJ; Kuenen MA; Klijn JG; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1081-91. PubMed ID: 16446057
[TBL] [Abstract][Full Text] [Related]
29. Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.
Hjelle LV; Gundersen POM; Hellesnes R; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Bremnes RM; Haugnes HS
Acta Oncol; 2018 Oct; 57(10):1392-1400. PubMed ID: 29775128
[TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.
Gerl A; Schierl R
Acta Oncol; 2000; 39(4):519-22. PubMed ID: 11041115
[TBL] [Abstract][Full Text] [Related]
31. Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.
Hallemeier CL; Davis BJ; Pisansky TM; Choo R
Urol Oncol; 2014 May; 32(4):496-500. PubMed ID: 24332645
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
Hohnloser JH; Schierl R; Hasford B; Emmerich B
Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
[TBL] [Abstract][Full Text] [Related]
33. Treatment of testicular cancer and the development of secondary malignancies.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
[TBL] [Abstract][Full Text] [Related]
34. Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
Lauritsen J; Kier MG; Mortensen MS; Bandak M; Gupta R; Holm NV; Agerbaek M; Daugaard G
J Clin Oncol; 2015 Oct; 33(28):3116-23. PubMed ID: 26240225
[TBL] [Abstract][Full Text] [Related]
35. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
[TBL] [Abstract][Full Text] [Related]
36. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis.
Powles T; Robinson D; Shamash J; Moller H; Tranter N; Oliver T
Ann Oncol; 2008 Mar; 19(3):443-7. PubMed ID: 18048383
[TBL] [Abstract][Full Text] [Related]
37. Noncancer causes of death in survivors of testicular cancer.
Fosså SD; Gilbert E; Dores GM; Chen J; McGlynn KA; Schonfeld S; Storm H; Hall P; Holowaty E; Andersen A; Joensuu H; Andersson M; Kaijser M; Gospodarowicz M; Cohen R; Pukkala E; Travis LB
J Natl Cancer Inst; 2007 Apr; 99(7):533-44. PubMed ID: 17405998
[TBL] [Abstract][Full Text] [Related]
38. Mortality and cancer incidence following radiotherapy for seminoma of the testis.
Horwich A; Bell J
Radiother Oncol; 1994 Mar; 30(3):193-8. PubMed ID: 8209001
[TBL] [Abstract][Full Text] [Related]
39. Long-term complications of platinum-based chemotherapy in testicular cancer survivors.
Oh JH; Baum DD; Pham S; Cox M; Nguyen ST; Ensor J; Chen I
Med Oncol; 2007; 24(2):175-81. PubMed ID: 17848741
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
